Drug therapies for stroke and traumatic brain injury often display U-shaped dose responses: occurrence, mechanisms, and clinical implications.

Drug therapies for stroke and traumatic brain injury often display U-shaped dose responses: occurrence, mechanisms, and clinical implications.

Item
http://www.wikidata.org/entity/Q37211892
Heat shock proteins and hormesis in the diagnosis and treatment of neurodegenerative diseasesCellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disordersDelayed treatment with systemic (S)-roscovitine provides neuroprotection and inhibits in vivo CDK5 activity increase in animal stroke modelsTNF-α and Microglial Hormetic Involvement in Neurological Health & MigraineStrategies for study of neuroprotection from cold-preconditioningCold pre-conditioning neuroprotection depends on TNF-α and is enhanced by blockade of interleukin-11.Hormesis and medicine.Monomeric IgG is neuroprotective via enhancing microglial recycling endocytosis and TNF-alpha.Hormesis is central to toxicology, pharmacology and risk assessment.Effects of Dimeric PSD-95 Inhibition on Excitotoxic Cell Death and Outcome After Controlled Cortical Impact in Rats.Hormesis, cellular stress response, and redox homeostasis in autism spectrum disorders.Hormesis: its impact on medicine and health.Cyclin-dependent kinase inhibition with roscovitine: neuroprotection in acute ischemic stroke.Glycogen synthase kinase-3 inhibition reduces ischemic cerebral damage, restores impaired mitochondrial biogenesis and prevents ROS production.Longitudinal monoaminergic PET imaging of chronic proteasome inhibition in minipigs
P2860

Drug therapies for stroke and traumatic brain injury often display U-shaped dose responses: occurrence, mechanisms, and clinical implications.

Item
http://www.wikidata.org/entity/Q37211892
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Drug therapies for stroke and ...... ms, and clinical implications.
@en
Drug therapies for stroke and ...... ms, and clinical implications.
@nl
type
label
Drug therapies for stroke and ...... ms, and clinical implications.
@en
Drug therapies for stroke and ...... ms, and clinical implications.
@nl
prefLabel
Drug therapies for stroke and ...... ms, and clinical implications.
@en
Drug therapies for stroke and ...... ms, and clinical implications.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Drug therapies for stroke and ...... ms, and clinical implications.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921